1.
Oncoimmunology
; 3(10): e956013, 2014 Nov.
Artículo
en Inglés
| MEDLINE
| ID: mdl-25941576
RESUMEN
Inhibition of MYC has been postulated as one of the most promising anti-tumoral therapies. However, if some anti-inflammatory cells express MYC, would an anti-tumoral treatment targeting MYC facilitate subsequent inflammation-related disorders?
